Core Viewpoint - Maris-Tech Ltd. has initiated commercial activities in the Ukrainian drone video payload market, leveraging its Jupiter product line for AI-powered edge video solutions [1][2]. Group 1: Company Overview - Maris-Tech is a global leader in video and AI-based edge computing technology, focusing on mission-critical defense and security operations [4]. - The company's solutions are designed for real-time video processing and AI capabilities at the edge, particularly for unmanned aerial vehicles (UAVs) [2][4]. - Maris-Tech's platforms are utilized across various applications, including UAVs, unmanned ground vehicles (UGVs), armored vehicles, and dismounted soldier systems, emphasizing ultra-low-latency video processing and onboard AI analytics [4]. Group 2: Market Activity - The initial transaction in Ukraine was facilitated through a third-party Israeli company, which purchased and supplied the systems to end users [3]. - The Ukrainian drone market is characterized as a demanding operational environment, driving the adoption of advanced video and AI technologies [4].

Core Viewpoint - VEON Ltd. has announced the date for its 2026 Annual General Meeting of Shareholders (AGM) to be held on May 11, 2026, with a record date set for March 31, 2026 [1]. Group 1: Board of Directors and Nominees - The Board and its Nomination Committee have recommended the re-election of seven current Board members, including notable figures such as Michael R. Pompeo and CEO Kaan Terzioglu [2]. - The Chairman of the Board, Augie K Fabela II, emphasized that VEON's performance in 2025 demonstrates the effectiveness of its strategy, which includes a significant 84.1% year-over-year growth in digital revenues, contributing to 20.1% of Group revenue in Q4 2025 [3]. Group 2: AGM Agenda and External Auditor - The AGM agenda will also include the re-appointment of UHY LLP as the external auditor for the financial year ending December 31, 2026, along with the presentation of the auditor's report and the audited financial statements for the year ended December 31, 2025 [3]. - Further details regarding the AGM, including biographies of the nominees and procedural matters, will be provided to registered shareholders prior to the meeting [4]. Group 3: Company Overview - VEON operates as a digital operator, providing connectivity and digital services to over 150 million connectivity users and more than 205 million digital users across five countries, impacting over 6% of the world's population [5].

Core Insights - Mama's Creations, Inc. will release its financial results for the fiscal fourth quarter ended January 31, 2026, on April 14, 2026, after market close [1] - The company has shown strong organic momentum and has successfully integrated its acquisition of Crown 1 and the Bay Shore facility, leading to a unified platform for future growth [3] - The company aims to become a $1 billion deli prepared foods company by 2030, focusing on expanding its presence with Tier-1 national retailers [4] Financial Results and Conference Call - An investor conference call will be held on April 14, 2026, at 4:30 p.m. Eastern time to discuss the fourth quarter fiscal 2026 financial results and provide a corporate update [2] - Participants are encouraged to join the call at least five minutes early to ensure timely participation [2] Company Overview - Mama's Creations, Inc. is a leading marketer and manufacturer of fresh deli prepared foods, available in over 12,000 grocery, mass, club, and convenience stores across the nation [5] - The company offers a diverse portfolio of high-quality, fresh, and easy-to-prepare foods, aiming to meet the evolving demands of modern consumers [5]

Core Insights - Aware, Inc. has demonstrated strong performance in the U.S. Department of Homeland Security's Remote Identity Validation Rally, showcasing its commitment to secure identity verification solutions [1][4][5] Group 1: Performance and Evaluation - Aware's Intelligent Liveness solution combines active liveness detection with passive usability, providing both security and user experience [3][5] - In the active liveness evaluation, Aware achieved zero successful attacks across attack classes A and B, maintaining a biometric presentation attack detection error rate (BPCER) below 5% [5] - The system ranked in the top three for user satisfaction on both iOS and Android platforms and was among the top two in efficiency, indicating that high security can coexist with a positive user experience [5][6] Group 2: Industry Context and Importance - The evolution of identity threats necessitates robust liveness detection to verify real user presence in digital interactions, making real-world testing essential [2][4] - The DHS Remote Identity Validation Rally sets a higher standard for evaluating identity technologies by incorporating realistic attack scenarios and live human participants [7][8] - Aware emphasizes the importance of independent testing, particularly active liveness evaluations, as critical for assessing performance, security, and usability in biometric solutions [8][10] Group 3: Future Commitment - Aware is committed to ongoing participation in independent testing and collaboration with industry and government partners to enhance biometric security [10] - The company aims to advance the industry by combining rigorous evaluation with continuous innovation, striving for a future where identity verification is both secure and user-friendly [10]

Core Viewpoint - Data Storage Corporation has postponed its fiscal year 2025 investor conference call to allow more time for the completion of its year-end audit due to the complexity of significant transactions during the fiscal year [1] Group 1: Company Announcements - The postponement is attributed to several significant transactions, including the sale of its CloudFirst subsidiary, the classification and settlement of outstanding warrants, and the completion of a tender offer [1] - The company will announce a new date and time for the conference call to report its fiscal year 2025 results as soon as possible [1] Group 2: Company Overview - Data Storage Corporation, through its subsidiary Nexxis, Inc., provides VoIP/Unified Communications and dedicated internet connectivity as part of its one-stop solution set [2] - The company plans to invest in and support businesses in areas such as GPU Infrastructure, AI-driven software applications, cybersecurity, and voice/data telecommunications [2] - The mission of the company is to build sustainable, recurring revenue streams while maintaining financial discipline and strategic focus [2]

Core Insights - Tarsus Pharmaceuticals has initiated a Phase 2 clinical trial (Calliope) for TP-05 (lotilaner), an investigational oral therapy aimed at preventing Lyme disease by killing infected ticks before disease transmission occurs [1][2][3] Company Overview - Tarsus Pharmaceuticals focuses on innovative treatments across various therapeutic areas, including eye care, dermatology, and infectious disease prevention [7][8] - The company is advancing its pipeline with TP-05 for Lyme disease prevention and TP-04 for ocular rosacea, both currently in Phase 2 trials [8] Clinical Trial Details - The Calliope trial is a randomized, double-blind, placebo-controlled study involving approximately 700 healthy adults at risk for Lyme disease, with enrollment expected to complete during the 2026 tick season and topline results anticipated in the first half of 2027 [2][3] - The trial design is based on previous successful studies, including a Phase 2a proof-of-concept study that demonstrated over 90% tick mortality within 24 hours of TP-05 administration [4] Lyme Disease Context - Lyme disease is the most common vector-borne disease in the U.S., with over 35 million Americans at moderate to high risk and approximately 300,000 to 400,000 diagnosed annually [3][6] - There are currently no FDA-approved pharmacological prophylactic options for Lyme disease, highlighting the need for innovative preventive measures [3][6] Scientific and Public Health Implications - The shift from treating Lyme disease post-infection to a preventive approach could significantly impact public health, especially as climate change expands the geographic range of ticks [3][6] - New prophylactic options like TP-05 could address the increasing burden of tick-borne illnesses and reduce the risk of serious long-term complications associated with Lyme disease [3][6]

Core Insights - Nuwellis, Inc. has expanded its pediatric footprint to 47 centers nationwide, including six of the top 10 children's hospitals, highlighting the strategic importance of this category [2][3] Pediatric Growth - The pediatric category now accounts for approximately 50% of total U.S. revenue, marking a significant milestone for the company [2] - Strong utilization is observed within established programs, with growing interest from additional centers for precision fluid management solutions for complex pediatric patients [2][4] Aquadex Therapy Platform - The Aquadex therapy platform is FDA-cleared for use in pediatric and adult patients weighing 20 kg and above, designed for precise ultrafiltration to manage fluid overload in critically ill children [3] - Continued pediatric expansion is viewed as a strategic growth catalyst, supported by high-acuity use cases and institutional adoption [3][4] Institutional Adoption - Adoption within leading pediatric centers reflects the increasing recognition of the need for precision fluid management in vulnerable populations [4] - The company aims to support clinical evidence development and expand market access as part of its strategy [4] Company Overview - Nuwellis, Inc. focuses on advancing precision fluid management technologies across the cardiorenal continuum, developing solutions for both acute and chronic care settings [5] - The company's portfolio includes technologies addressing complex cardiorenal conditions, emphasizing safety, precision, and scalability [5] Aquadex SmartFlow System - The Aquadex SmartFlow system is indicated for temporary or extended use in patients weighing 20 kg or more, specifically for those whose fluid overload is unresponsive to medical management [6] - Treatments must be administered by trained healthcare providers in clinical settings under physician prescription [6]

Core Insights - BlockchAIn Digital Infrastructure, Inc. completed its business combination with Signing Day Sports, Inc. and began trading on NYSE American under the ticker symbol "AIB" on March 17, 2026, marking a significant milestone for the company [2][3] - The company operates a 40 MW data center in South Carolina and has a documented 200 MW power pipeline, with plans to expand its capacity and develop additional AI-focused sites [3][4] - The demand for AI and high-performance computing (HPC) infrastructure is increasing, driven by enterprise adoption and cloud expansion, while the industry faces constraints in power availability and deployment-ready facilities [4][7] Company Developments - The company has letters of intent for a 5 MW and a 20 MW deployment, which, if converted into definitive agreements, could represent over $500 million in potential contract value [5][8] - Collaborations with Supermicro and Power and Data Management are expected to enhance access to high-density compute hardware and critical electrical infrastructure, supporting the company's modular deployment strategy [6][10] - The company aims to expand its South Carolina campus from 40 MW to 50 MW and is developing a 25 MW AI-focused data center in Minnesota [8][10] Financial Performance - For FY 2025, the company reported revenues of approximately $18.5 million, a decrease from $22.9 million in FY 2024, with a net loss of approximately $0.8 million compared to a net income of $5.7 million in FY 2024 [13][14] - Adjusted EBITDA for FY 2025 was approximately $1.7 million, down from $6.2 million in FY 2024, primarily due to lower revenues and increased costs [19][22] - The company maintained positive operating cash flow of approximately $2.3 million and positive stockholders' equity of $7.9 million as of March 26, 2026 [15][19] Growth Strategy - The company's growth strategy includes a multi-site development pipeline targeting approximately 715 MW of total capacity, supported by a capital plan of approximately $9.9 billion for development from 2026 to 2030 [10][15] - The company plans to fund its development through project-level debt and privately placed equity, retaining an economic interest through management fees and a promoted interest structure [10][15] - Management believes that the recent letters of intent reflect early commercial engagement and validate the company's strategy of developing power-secured, AI-ready infrastructure [15][19]

Core Insights - KOIL Energy Solutions, Inc. reported a record revenue of $7.3 million for Q4 2025, reflecting a 22% year-over-year growth and a 14% increase from the previous quarter [3][5] - The company achieved an adjusted EBITDA margin of 10%, with a total adjusted EBITDA of $704,000 for the quarter [2][4] Financial Performance - **Fourth Quarter 2025 Results**: - Revenue reached $7.3 million, a 22% increase compared to Q4 2024 and a 14% increase from Q3 2025 [3] - Service revenue grew by 24%, while fixed-priced contracts increased by 21% year-over-year [3] - Gross profit was $2.5 million, representing a gross margin of 35%, down from 40% in Q4 2024 [4] - Selling, general, and administrative expenses rose to $2.1 million, an increase of $237,000 from the prior year [4] - **Full Year 2025 Results**: - Total revenue for 2025 was $24 million, marking a 6% increase from 2024 [5] - Adjusted EBITDA for the year was $1 million, a decrease from $3.5 million in 2024, primarily due to investments in growth initiatives [5] Strategic Initiatives - The company is focused on long-term growth, investing free cash flow into acquiring new rental equipment and developing intellectual property [5] - KOIL is establishing operations in Brazil and expanding international sales, with positive growth results already being observed [5] - Future growth strategies and ambitious goals will be presented at an investor conference in Houston on May 7-8, 2026 [5] Market Position - KOIL Energy is recognized as a leading energy services company, specializing in subsea equipment and support services for the energy and offshore industries [8] - The company aims to provide innovative solutions to complex challenges faced in energy production and distribution [8]

Core Insights - Onconetix, Inc. has appointed David White as Chief Executive Officer and Sammy Dorf to its Board of Directors, reflecting a strategic move to enhance leadership as the company prepares for the acquisition of Realbotix LLC, a developer of AI-powered humanoid robots [1][2][3] Leadership Appointments - David White brings over 30 years of executive experience, having held CEO, CFO, and COO roles in various sectors including transportation and healthcare. He has served on multiple public company boards and holds a CPA designation [2][4] - Sammy Dorf is an entrepreneur and investor with a strong background in capital markets and corporate governance. He co-founded Verano Holdings Corp. and has held significant roles in public companies, contributing to their strategic transformations [3][4] Acquisition of Realbotix - The acquisition of Realbotix is seen as a transformative opportunity for Onconetix, positioning the company at the intersection of AI and humanoid robotics, which is a rapidly evolving sector [3][5] - The leadership team believes that the acquisition will create significant value for shareholders and is focused on executing the transaction successfully [5][6] Company Background - Onconetix, Inc. is a commercial-stage biotechnology company specializing in innovative oncology solutions, including Proclarix®, an in vitro diagnostic test for prostate cancer [6] - Realbotix LLC, the target of the acquisition, develops AI-powered humanoid robots designed for human interaction, with patented technologies enabling lifelike expressions and social engagement [7]